Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investments (Tables)
|
6 Months Ended |
Jun. 30, 2024 |
| Marketable Investment Securities, Restricted Cash and Cash Equivalents, and Other Investments |
|
| Schedule of marketable investment securities, restricted cash and cash equivalents, and other investments |
| | | | | | | | | As of | | | June 30, | | December 31, | | | 2024 | | 2023 | | | | (In thousands) | Marketable investment securities: | | | | | | | Current marketable investment securities: | | | | | | | Strategic - available-for-sale | | $ | 149 | | $ | 144 | Strategic - trading/equity | | | 100,222 | | | 176,205 | Other | | | 960 | | | 446,695 | Total current marketable investment securities | | | 101,331 | | | 623,044 | Restricted marketable investment securities (1) | | | 16,048 | | | 27,840 | Total marketable investment securities | | | 117,379 | | | 650,884 | | | | | | | | Restricted cash and cash equivalents (1) | | | 127,381 | | | 90,225 | | | | | | | | Other investments, net: | | | | | | | Equity method investments | | | 94,483 | | | 169,038 | Cost method investments | | | 109,509 | | | 106,134 | Fair value method and other debt investments | | | 39,199 | | | 39,198 | Total other investments, net | | | 243,191 | | | 314,370 | | | | | | | | Total marketable investment securities, restricted cash and cash equivalents, and other investments, net | | $ | 487,951 | | $ | 1,055,479 |
| (1) | Restricted marketable investment securities and restricted cash and cash equivalents are included in “Restricted cash, cash equivalents and marketable investment securities” on our Condensed Consolidated Balance Sheets. |
|
| Schedule of fair value measurements |
| | | | | | | | | | | | | | | | | | | | | | | | | | | As of | | | June 30,2024 | | December 31, 2023 | | | Total | | Level 1 | | Level 2 | | Level 3 | | Total | | Level 1 | | Level 2 | | Level 3 | | | | (In thousands) | Cash equivalents (including restricted) | | $ | 320,984 | | $ | 192,935 | | $ | 128,049 | | $ | — | | $ | 1,692,849 | | $ | 573,504 | | $ | 1,119,345 | | $ | — | | | | | | | | | | | | | | | | | | | | | | | | | | Debt securities (including restricted): | | | | | | | | | | | | | | | | | | | | | | | | | U.S. Treasury and agency securities | | $ | 17,007 | | $ | 17,007 | | $ | — | | $ | — | | $ | 65,172 | | $ | 65,172 | | $ | — | | $ | — | Commercial paper | | | — | | | — | | | — | | | — | | | 290,398 | | | — | | | 290,398 | | | — | Corporate securities | | | — | | | — | | | — | | | — | | | 114,265 | | | — | | | 114,265 | | | — | Other | | | 150 | | | — | | | 1 | | | 149 | | | 4,844 | | | — | | | 4,700 | | | 144 | Equity securities | | | 100,222 | | | 92,156 | | | 8,066 | | | — | | | 176,205 | | | 166,481 | | | 9,724 | | | — | Total | | $ | 117,379 | | $ | 109,163 | | $ | 8,067 | | $ | 149 | | $ | 650,884 | | $ | 231,653 | | $ | 419,087 | | $ | 144 |
|
| Schedule of gains and losses on sales and changes in carrying amounts of investments and other |
| | | | | | | | | | | | | | | For the Three Months Ended | | For the Six Months Ended | | | June 30, | | June 30, | Other, net: | | 2024 | | 2023 | | 2024 | | 2023 | | | | (In thousands) | Marketable and non-marketable investment securities - realized and unrealized gains (losses) | | $ | (25,417) | | $ | 3,840 | | $ | (49,312) | | $ | (3,577) | Derivative instruments - net realized and/or unrealized gains (losses) | | | — | | | (8,013) | | | — | | | (36,974) | Other investment securities - other-than-temporary impairments | | | — | | | (33,400) | | | — | | | (33,400) | Gains (losses) related to early redemption of debt | | | — | | | 68,037 | | | — | | | 68,086 | Foreign currency transaction gains (losses) | | | (2,702) | | | 3,125 | | | (3,329) | | | 6,297 | Equity in earnings (losses) of affiliates | | | (66,397) | | | (1,475) | | | (69,183) | | | (3,478) | Other | | | 3,018 | | | 1,954 | | | 4,216 | | | 2,353 | Total | | $ | (91,498) | | $ | 34,068 | | $ | (117,608) | | $ | (693) | | | | | | | | | | | | | |
|